MENU
+Compare
SYNB
ETF ticker:
AS OF
Nov 13 closing price
Price
$31.61
Change
+$0.59 (+1.90%)
Net Assets
1.58M

SYNB stock forecast, quote, news & analysis

SYNB
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SYNB with price predictions
Dec 24, 2025

Momentum Indicator for SYNB turns positive, indicating new upward trend

SYNB saw its Momentum Indicator move above the 0 level on November 19, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator turned positive. In of the 51 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 152 cases where SYNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SYNB turned negative on November 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 26 similar instances when the indicator turned negative. In of the 26 cases the stock turned lower in the days that followed. This puts the odds of success at .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), Biogen (NASDAQ:BIIB), Exact Sciences Corp (NASDAQ:EXAS), DuPont de Nemours (NYSE:DD).

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 280.17B. The market cap for tickers in the group ranges from 379.86M to 4.58T. NVDA holds the highest valuation in this group at 4.58T. The lowest valued company is RCKT at 379.86M.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 0%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was 15%. BMRN experienced the highest price growth at 16%, while BG experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was -69%. For the same stocks of the ETF, the average monthly volume growth was -77% and the average quarterly volume growth was -80%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 66
Price Growth Rating: 45
SMR Rating: 66
Profit Risk Rating: 67
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
SYNB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Unknown

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A